Nice Weekend Weather… “Earth Gauge”: Asthma & Air Quality, Water Photo Contest – WOKV (blog)


WOKV (blog)

Nice Weekend Weather… "Earth Gauge": Asthma & Air Quality, Water Photo Contest
WOKV (blog)
Are you one of the 24 million people living in the United States affected by asthma? More than 1,000 people are admitted to the hospital each day because of this chronic lung disease, which costs the nation around $56 billion each year in both direct

and more »

View full post on asthma – Google News

A First: NICE Drafts New Guidance to Improve Accuracy of Asthma Diagnosis – Maine News


Maine News

A First: NICE Drafts New Guidance to Improve Accuracy of Asthma Diagnosis
Maine News
The National Institute for Health and Care Excellence (NICE) has warned that over one million people who were treated for asthma might have been misdiagnosed. The health watchdog stated that the studies have unveiled that up to 30% of the 4.1 million …

View full post on asthma – Google News

NICE backs FeNO devices for asthma diagnosis – Nursing Times


Gloucestershire Echo

NICE backs FeNO devices for asthma diagnosis
Nursing Times
It has recommended three devices – NIOX MINO, NIOX VERO and NObreath – to measure the levels of fractional-exhaled nitric oxide (FeNO) a patient is breathing out that are indicative of inflammation associated with asthma. The institute's guidance …
Asthma sufferers recommended breath test pioneered in GloucestershireGloucestershire Echo
Search for jobs in the North EastThe Journal

all 3 news articles »

View full post on asthma – Google News

NICE Turnaround On Novartis’ Xolair To Be Discussed At Asthma & Copd … – Big News Network.com

NICE Turnaround On Novartis' Xolair To Be Discussed At Asthma & Copd
Big News Network.com
asthma in adults, adolescents and children. The decision comes as a result of a move by Novartis to offer a patient access scheme to discount Xolair's list price. An estimated 65 million people currently suffer from COPD globally with 300 million

View full post on asthma – Google News

NICE U-turn on Novartis’ Xolair for asthma – PharmaTimes

NICE U-turn on Novartis' Xolair for asthma
PharmaTimes
The National Institute for Health and Clinical Excellence said it now recommends Xolair (omalizumab) as an option for treating severe, persistent allergic asthma in adults, adolescents and children, in a complete turnaround from its earlier intention
Asthma treatment – double U-turnWebMD.Boots.com
Life-changing jab gives hope to asthma sufferersExpress.co.uk
NICE approves use of asthma drug omalizumabOnMedica
The Daily Telegraph –GP online
all 10 news articles »

View full post on asthma – Google News

NICE sets out new standards for asthma care – Nursing Times

NICE sets out new standards for asthma care
Nursing Times
It says the new guidelines on the diagnosis and treatment of asthma in adults, young people and children aged 12 months and older will lead to improved care for patients. The new quality standard, published on February 21, comprises 11 statements that
NICE's new asthma quality standard "could change millions of lives"PharmaTimes
New integrated approach to asthma careWebMD.Boots.com
New asthma care 'could change millions of lives'ITV News

all 4 news articles »

View full post on asthma – Google News

UK’s NICE rejects Novartis asthma drug in change of tack – Reuters


Daily Mail

UK's NICE rejects Novartis asthma drug in change of tack
Reuters
Health ». LONDON | Thu Nov 8, 2012 7:06pm EST. LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE plans to recommend against the use of Novartis's severe asthma drug Xolair, or omalizumab, after earlier endorsing it for adults only.
Now English asthma patients are denied life-changing drug offered to ScotsDaily Mail
Asthma drug life changing: swimmerMSN News UK

all 16 news articles »

View full post on asthma – Google News